A Netflix-style scheme that funds new antibiotics through subscriptions (medical services pay a fixed annual fee to pharmaceutical companies, regardless of how many times they are used) will be launched in the UK next year.
This approach addresses a key component of the antibiotic resistance crisis. While existing drugs are failing, few new drugs are being developed. This area is currently unprofitable for pharmaceutical companies as new antibiotics arrive in the clinic and medical services use them sparingly and slow their spread …
NHS England tests Netflix-style subscriptions for antibiotics
Source link NHS England tests Netflix-style subscriptions for antibiotics